Brief: I Teos Therapeutics Inc Expected Severance Costs Of $21.8 Million To $24.7 Million
28/05/2025 15:36
May 28 (Reuters) - Iteos Therapeutics Inc ITOS.O: ITEOS THERAPEUTICS INC - EXPECTED SEVERANCE COSTS OF $21.8 MILLION TO $24.7 MILLION Further company coverage: ITOS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on iTeos Therapeutics
See all newsIteos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Iteos Therapeutics Inc expected to post a loss of $1.01 a share - Earnings Preview
Brief: Iteos Therapeutics Enters Into Agreement To Be Acquired By Concentra Biosciences For $10.047 In Cash Per Share Plus A Contingent Value Right
U.S. STOCKS ON THE MOVE-Nvidia, Salesforce, Kestrel Group
U.S. STOCKS ON THE MOVE-Dick's Sporting Goods, Sonic Automotive